• Je něco špatně v tomto záznamu ?

Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method

D. Stejskal, B. Lacnak, L. Jedelsky, L. Stepanova, J. Proskova, P. Solichova, L. Kadalova, M. Janosova, P. Seitlova, M. Karpisek, L. Sprongl

. 2007 ; 151 (2) : 247-249.

Jazyk angličtina Země Česko

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc13003608

BACKGROUND: Glycogen Phosphorylase BB (GPBB) is considered an early and specific marker of myocardial necrosis and ischemia. A POCT kit GPBB for diagnostic use has recently been approved. AIM: an evaluation of the correspondence of qualitative POCT GBPP measurements with ELISA test results. MATERIAL AND METHODOLOGY: 20 individuals with non-ST elevation myocardial infarction (non-STEMI) and 20 probands without acute coronary syndrome (ACS) were tested. GPBB (POCT, ELISA) in venous plasma (lithium-heparin) was assayed in all probands. RESULTS: individuals with non-STEMI had significantly higher GPBB ELISA values (32.3 vs. 6.1 microg/l; p < 0.01). GPBB sensitivity and specificity for non-STEMI presence 6 hours after chest pain generation were 100 %. No proband was classified in a different subgroup with POCT of GPBB (positive/negative). GPBB POCT correlate with a non- STEMI diagnosis (chi(2) 36.1; p <0.01). CONCLUSION: GPBB POCT measurement is comparable with ELISA test results. GPBB analysis could expand the diagnostic palette in the first hours after the onset of acute coronary syndrome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13003608
003      
CZ-PrNML
005      
20130222140440.0
007      
ta
008      
130128s2007 xr f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2007.041 $2 doi
035    __
$a (PubMed)18345258
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Stejskal, David, $d 1967- $7 xx0042302 $u Department of Laboratory Medicine, Sternberk Hospital
245    10
$a Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method / $c D. Stejskal, B. Lacnak, L. Jedelsky, L. Stepanova, J. Proskova, P. Solichova, L. Kadalova, M. Janosova, P. Seitlova, M. Karpisek, L. Sprongl
520    9_
$a BACKGROUND: Glycogen Phosphorylase BB (GPBB) is considered an early and specific marker of myocardial necrosis and ischemia. A POCT kit GPBB for diagnostic use has recently been approved. AIM: an evaluation of the correspondence of qualitative POCT GBPP measurements with ELISA test results. MATERIAL AND METHODOLOGY: 20 individuals with non-ST elevation myocardial infarction (non-STEMI) and 20 probands without acute coronary syndrome (ACS) were tested. GPBB (POCT, ELISA) in venous plasma (lithium-heparin) was assayed in all probands. RESULTS: individuals with non-STEMI had significantly higher GPBB ELISA values (32.3 vs. 6.1 microg/l; p < 0.01). GPBB sensitivity and specificity for non-STEMI presence 6 hours after chest pain generation were 100 %. No proband was classified in a different subgroup with POCT of GPBB (positive/negative). GPBB POCT correlate with a non- STEMI diagnosis (chi(2) 36.1; p <0.01). CONCLUSION: GPBB POCT measurement is comparable with ELISA test results. GPBB analysis could expand the diagnostic palette in the first hours after the onset of acute coronary syndrome.
650    _2
$a akutní koronární syndrom $x krev $x diagnóza $7 D054058
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a ELISA $7 D004797
650    _2
$a glykogenfosforylasa $x krev $7 D024981
650    _2
$a lidé $7 D006801
650    _2
$a izoenzymy $x krev $7 D007527
650    _2
$a infarkt myokardu $x diagnóza $7 D009203
650    _2
$a vyšetření u lůžka $7 D019095
650    _2
$a reagenční diagnostické soupravy $7 D011933
650    _2
$a senzitivita a specificita $7 D012680
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lačňák, Bořek $7 xx0062287 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Jedelský, Libor $7 xx0074161 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Štěpánová, Leona. $7 xx0246683 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Prošková, Jitka. $7 xx0230492 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Kušnierová, Pavlína, $d 1978- $7 xx0140526 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Kadalová, Lenka, $d 1977- $7 xx0117662 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Jánošová, Marie $7 xx0104718 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Seitlová, Petra $7 xx0134482 $u Department of Laboratory Medicine, Sternberk Hospital
700    1_
$a Karpíšek, Michal $7 xx0107472 $u Institute of Human Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, Veterinary and Pharmaceutical University Brno
700    1_
$a Šprongl, Luděk, $d 1956- $7 pag2009484917 $u Central Laboratory, Sumperk Hospital
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 151, č. 2 (2007), s. 247-249
910    __
$a ABA008 $b A 1502 $c sign $y 3 $z 0
990    __
$a 20130128 $b ABA008
991    __
$a 20130222140634 $b ABA008
999    __
$a ok $b bmc $g 966264 $s 801803
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2007 $b 151 $c 2 $d 247-249 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK111 $a Pubmed-20130128

Najít záznam

Citační ukazatele

Možnosti archivace